NGLY1 and central nervous system cancer: To explore the glycosylation status of PTPRZ in glioma, we treated sPTPRZ in CSF from glioma patients with several kinds of glycosidases: chondroitinase ABC (ChABC), end-β-galactosidase, sialidase, and peptide-N-glycosidase (PNGase).